{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_Display\ Name in Display Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 332
(2013)
Source URL:
First approved in 1960
Source:
NDA012546
Source URL:
Class:
POLYMER
Status:
US Approved Rx
(2015)
First approved in 2015
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2015)
First approved in 2015
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2015)
First approved in 2015
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2007)
First approved in 2007
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2007)
First approved in 2007
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2009)
First approved in 1998
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2000)
First approved in 1993
Source:
BLA103935
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2001)
First approved in 1989
Source:
BLA103239
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2017)
First approved in 1986
Source:
BLA101066
Source URL:
Class:
STRUCTURALLY DIVERSE
